Your browser doesn't support javascript.
Machine learning techniques applied to the drug design and discovery of new antivirals: a brief look over the past decade.
Serafim, Mateus Sá Magalhães; Dos Santos Júnior, Valtair Severino; Gertrudes, Jadson Castro; Maltarollo, Vinícius Gonçalves; Honorio, Kathia Maria.
  • Serafim MSM; Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • Dos Santos Júnior VS; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • Gertrudes JC; Departamento de Computação, Instituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto (UFOP), Ouro Preto, Brazil.
  • Maltarollo VG; Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
  • Honorio KM; Escola de Artes, Ciências e Humanidades, Universidade de São Paulo (USP), São Paulo, Brazil.
Expert Opin Drug Discov ; 16(9): 961-975, 2021 09.
Article in English | MEDLINE | ID: covidwho-1219967
ABSTRACT

Introduction:

Drug design and discovery of new antivirals will always be extremely important in medicinal chemistry, taking into account known and new viral diseases that are yet to come. Although machine learning (ML) have shown to improve predictions on the biological potential of chemicals and accelerate the discovery of drugs over the past decade, new methods and their combinations have improved their performance and established promising perspectives regarding ML in the search for new antivirals.Areas covered The authors consider some interesting areas that deal with different ML techniques applied to antivirals. Recent innovative studies on ML and antivirals were selected and analyzed in detail. Also, the authors provide a brief look at the past to the present to detect advances and bottlenecks in the area.Expert opinion From classical ML techniques, it was possible to boost the searches for antivirals. However, from the emergence of new algorithms and the improvement in old approaches, promising results will be achieved every day, as we have observed in the case of SARS-CoV-2. Recent experience has shown that it is possible to use ML to discover new antiviral candidates from virtual screening and drug repurposing.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Design / Machine Learning Type of study: Diagnostic study / Prognostic study Limits: Animals / Humans Language: English Journal: Expert Opin Drug Discov Year: 2021 Document Type: Article Affiliation country: 17460441.2021.1918098

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Design / Machine Learning Type of study: Diagnostic study / Prognostic study Limits: Animals / Humans Language: English Journal: Expert Opin Drug Discov Year: 2021 Document Type: Article Affiliation country: 17460441.2021.1918098